Investigating the Effect of Extracorporeal Shock Wave Therapy on reducing Chronic Pain in Patients with Pes Anserine Bursitis: A Randomized, Clinical- Controlled Trial

Khosrawi, Saeid; Taheri, Parisa; Ketabi, Marziyeh

Investigating the Effect of Extracorporeal Shock Wave Therapy on reducing Chronic Pain in Patients with Pes Anserine Bursitis: A Randomized, Clinical- Controlled Trial

Document Type : Original Article

Authors

Department of Physical Medicine and Rehabilitation, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Knee pain, is one of the most common causes of patients' referring to physiatric clinics, and several factors, are involved in its creation. One of these factors is pes anserine bursitis (PAB) for which various treatment methods are used. This study aims to investigate the effect of this method on reducing chronic pain in these patients. Materials and Methods: This clinical trial was conducted in 2013- 2014 on patients with PAB referring to academic, physical medicine clinics. The patients with chronic PAB (pain duration more than 3 months), who were refractory to conservative treatments, were randomly divided into two 20-member experimental groups (extracorporeal shock wave therapy [ESWT] and sham ESWT). Pain scores of all patients were measured using the Visual Analog Scale (VAS) and McGill Pain Questionnaire (MPQ) (total and present pain indexes [TPIs and PPIs]) before intervention, immediately after intervention (3^rd week), and after 8 weeks. The pain scores were then compared and statistically analyzed. Results: In the ESWT group, the mean patient pain score of the VAS and TPI in MPQ were significantly lower than in the sham ESWT group immediately after intervention (3^rd week): P=0.02, P= 0.04 respectively; and 8 weeks after the end of treatment: P=0.01, P= 0.000. Moreover, the PPI in both groups had significantly decreased over time, although in ESWT group this decrement was significantly more than sham ESWT group (P < 0.001). Conclusion: The results showed that ESWT could be effective in reducing the pain and treating PAB.

Keywords

References

1.	Butcher JD, Salzman KL, Lillegard WA. Lower extremity bursitis. Am Fam Physician 1996;53:2317-24.
2.	Hansen PA, Willick SE. Musculoskeletal disorders of the lower limb. In: Braddom RL, editor. Physical Medicine & Rehabilitation. 4^th ed., Vol. 843. Philadeiphia, PA: Saunders; 2011. p. 59.
3.	Rennie WJ, Saifuddin A. Pes anserine bursitis: Incidence in symptomatic knees and clinical presentation. Skeletal Radiol 2005;34:395-8.
4.	Helfenstein M Jr, Kuromoto J. Anserine syndrome. Rev Bras Reumatol 2010;50:313-27.
5.	Voorneveld C, Arenson AM, Fam AG. Anserine bursal distention: Diagnosis by ultrasonography and computed tomography. Arthritis Rheum 1989;32:1335-8.
6.	Yoon HS, Kim SE, Suh YR, Seo YI, Kim HA. Correlation between ultrasonographic findings and the response to corticosteroid injection in pes anserinus tendinobursitis syndrome in knee osteoarthritis patients. J Korean Med Sci 2005;20:109-12.
7.	Uson J, Aguado P, Bernad M, Mayordomo L, Naredo E, Balsa A, et al. Pes anserinus tendino-bursitis: What are we talking about? Scand J Rheumatol 2000;29:184-6.
8.	Hanada ED, Keplinger FS, Gupta N. Knee bursitis. In: Forontera WR, Silver JK, Rizzo TD. Essentials of Physical Medicine and Rehabilitation. 7^th ed. Philadeiphia, PA: Saunders; 2008. p. 355-8.
9.	Forbes JR, Helms CA, Janzen DL. Acute pes anserine bursitis: MR imaging. Radiology 1995;194:525-7.
10.	Marra MD, Crema MD, Chung M, Roemer FW, Hunter DJ, Zaim S, et al. MRI features of cystic lesions around the knee. Knee 2008;15:423-38.
11.	Alvarez-Nemegyei J, Canoso JJ. Evidence-based soft tissue rheumatology IV: Anserine bursitis. J Clin Rheumatol 2004;10:205-6.
12.	Kang I, Han SW. Anserine bursitis in patients with osteoarthritis of the knee. South Med J 2000;93:207-9.
13.	Basford J. Physical agents. In: Delisa J, Gans B, editors. Rehabilatien Medicine: Principles and Practice. 3^rd ed. Philadelphia: JP Lippincott; 1998. p. 812-25.
14.	Notarnicola A, Moretti B. The biological effects of extracorporeal shock wave therapy (ESWT) on tendon tissue. Muscles Ligaments Tendons J 2012;2:33-7.
15.	Glencross PM, Consuelo TL. Pes Anserine Bursitis Treatment & Management. Available from: http://www.google.com/. [Last accessed on 2014 Feb 12].
16.	Zhao Z, Jing R, Shi Z, Zhao B, Ai Q, Xing G. Efficacy of extracorporeal shockwave therapy for knee osteoarthritis: A randomized controlled trial. J Surg Res 2013;185:661-6.
17.	Speed C. A systematic review of shockwave therapies in soft tissue conditions: Focusing on the evidence. Br J Sports Med 2014;48:1538-42.
18.	Furia JP, Rompe JD, Cacchio A, Del Buono A, Maffulli N. A single application of low-energy radial extracorporeal shock wave therapy is effective for the management of chronic patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc 2013;21:346-50.
19.	Smith J, Sellon JL. Comparing PRP injections with ESWT for athletes with chronic patellar tendinopathy. Clin J Sport Med 2014;24:88-9.
20.	Henk VD, Johannes Z, Inge VA, Ron LD. The TOPSHOCK Study: Effectiveness of radial shock wave therapy compared to focused shock wave therapy for treating pattelar tendinopath design of a randomized controlled trial. BMC Musculoskelet Disord 2012;12:229-36.
21.	Vahdatpour B, Sajadieh S, Bateni V, Karami M, Sajjadieh H. Extracorporeal shock wave therapy in patients with plantar fasciitis. A randomized, placebo-controlled trial with ultrasonographic and subjective outcome assessments. J Res Med Sci 2012;17:834-8.
22.	Vahdatpour B, Taheri P, Zade AZ, Moradian S. Efficacy of extracorporeal shockwave therapy in frozen shoulder. Int J Prev Med 2014;5:875-81.
23.	Vahdatpour B, Alizadeh F, Moayednia A, Emadi M, Khorami MH, Haghdani S. Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: A randomized, controlled trial. ISRN Urol 2013;2013:972601.
24.	Pires PR, Lui M. Effectiveness of Shock Wave Therapy in Patients with Pes Anserine Bursitis. IN: ISMST; 2009. Available from: http://www. Scholar.google.com/. [Last accessed on 2014 Jul 30].

Advanced Biomedical Research